Practical detection of t(14;18)(IgH/BCL2) in follicular lymphoma.
暂无分享,去创建一个
W. Chan | R. C. Hawley | K. Gu
[1] D. Arber,et al. ''Minor'' BCL2 breakpoints in follicular lymphoma: frequency and correlation with grade and disease presentation in 236 cases. , 2007, The Journal of molecular diagnostics : JMD.
[2] A. Ng,et al. Diffuse large B-cell lymphoma. , 2007, Seminars in radiation oncology.
[3] P. Dubus,et al. Interphase fluorescence in situ hybridization is more sensitive than BIOMED-2 polymerase chain reaction protocol in detecting IGH-BCL2 rearrangement in both fixed and frozen lymph node with follicular lymphoma. , 2007, Human pathology.
[4] N. Kernohan,et al. BCL2 gene abnormalities define distinct clinical subsets of follicular lymphoma , 2006, Histopathology.
[5] K. Reichard,et al. Automated analysis of fluorescence in situ hybridization on fixed, paraffin-embedded whole tissue sections in B-cell lymphoma , 2006, Modern Pathology.
[6] L. Cerroni,et al. Molecular Cytogenetic Evidence of t(14;18)(IGH;BCL2) in a Substantial Proportion of Primary Cutaneous Follicle Center Lymphomas , 2006, The American journal of surgical pathology.
[7] T. Kimlinger,et al. FISH is superior to PCR in detecting t(14;18)(q32;q21)-IgH/bcl-2 in follicular lymphoma using paraffin-embedded tissue samples. , 2005, American journal of clinical pathology.
[8] R. Buckstein,et al. What is remission in follicular lymphoma and what is its relevance? , 2005, Best practice & research. Clinical haematology.
[9] P. Batstone,et al. Efficacy of screening the intermediate cluster region of the bcl2 gene in follicular lymphomas by PCR , 2004, Journal of Clinical Pathology.
[10] S. Swerdlow,et al. Utility of routine classical cytogenetic studies in the evaluation of suspected lymphomas: results of 279 consecutive lymph node/extranodal tissue biopsies. , 2004, American journal of clinical pathology.
[11] M Hummel,et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: Report of the BIOMED-2 Concerted Action BMH4-CT98-3936 , 2003, Leukemia.
[12] S. Barrans,et al. The detection of t(14;18) in archival lymph nodes: development of a fluorescence in situ hybridization (FISH)-based method and evaluation by comparison with polymerase chain reaction. , 2003, The Journal of molecular diagnostics : JMD.
[13] E. Jaffe. Pathology and Genetics: Tumours of Haematopoietic and Lymphoid Tissues , 2003 .
[14] G. Dölken,et al. Chromosomal translocation t(14;18) in healthy individuals. , 2003, Seminars in cancer biology.
[15] G. Dewald,et al. A new method to extract nuclei from paraffin-embedded tissue to study lymphomas using interphase fluorescence in situ hybridization. , 2002, The American journal of pathology.
[16] M. Kurrer,et al. High frequency of t(14;18)-translocation breakpoints outside of major breakpoint and minor cluster regions in follicular lymphomas: improved polymerase chain reaction protocols for their detection. , 2002, The American journal of pathology.
[17] J. Aster,et al. Detection of BCL2 rearrangements in follicular lymphoma. , 2002, The American journal of pathology.
[18] R. Tubbs,et al. Use of novel t(11;14) and t(14;18) dual-fusion fluorescence in situ hybridization probes in the differential diagnosis of lymphomas of small lymphocytes. , 2001, Diagnostic molecular pathology : the American journal of surgical pathology, part B.
[19] T. Lister,et al. Frequency of the Bcl-2/IgH rearrangement in normal individuals: implications for the monitoring of disease in patients with follicular lymphoma. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[20] F. Jardin,et al. Characterisation of BCL2-JH rearrangements in follicular lymphoma: PCR detection of 3′ BCL2 breakpoints and evidence of a new cluster , 2000, Leukemia.
[21] G. Salles,et al. Variability of polymerase chain reaction detection of the bcl-2-IgH translocation in an international multicentre study. , 1999, Annals of oncology : official journal of the European Society for Medical Oncology.
[22] A. Sarris,et al. Novel 5' exonuclease-based real-time PCR assay for the detection of t(14;18)(q32;q21) in patients with follicular lymphoma. , 1998, The American journal of pathology.
[23] H. Ohno,et al. Refinement of the BCL2/immunoglobulin heavy chain fusion gene in t(14;18)(q32;q21) by polymerase chain reaction amplification for long targets , 1998, Genes, chromosomes & cancer.
[24] R. Gascoyne,et al. Comparison of cytogenetic analysis, southern analysis, and polymerase chain reaction for the detection of t(14; 18) in follicular lymphoma. , 1995, American journal of clinical pathology.
[25] J. Sklar,et al. Detection of a second t(14;18) breakpoint cluster region in human follicular lymphomas , 1986, The Journal of experimental medicine.
[26] J. Sklar,et al. Nucleotide sequence of a t(14;18) chromosomal breakpoint in follicular lymphoma and demonstration of a breakpoint-cluster region near a transcriptionally active locus on chromosome 18. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[27] P. Soubeyran,et al. Variability of quantitative polymerase chain reaction detection of the bcl-2-IgH translocation in an international multicenter study. , 2005, Haematologica.
[28] R. Gascoyne,et al. Low-grade lymphoma. , 2004, Hematology. American Society of Hematology. Education Program.
[29] A. Moreau,et al. Is t(14;18)(q32;q21) a constant finding in follicular lymphoma? An interphase FISH study on 63 patients , 2003, Leukemia.
[30] Cdm Fletcher,et al. World Health Organization Classification of Tumours , 2002 .